RT Book, Section A1 Dietrich, Eric A2 Angaran, David M. A2 Whalen, Karen SR Print(0) ID 1102489459 T1 Osteoarthritis Medication Therapy Management Data Set T2 Medication Therapy Management: A Comprehensive Approach YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071848695 LK accesspharmacy.mhmedical.com/content.aspx?aid=1102489459 RD 2024/03/29 AB Treatment goals for osteoarthritis should be identified prior to beginning treatment and individualized to the patient, with the goal of achieving an acceptable balance between minimizing pain and side effects as well as maximizing functionality along with quality of life.Optimal treatment of osteoarthritis includes both pharmacologic and nonpharmacologic therapies. Adherence to both should be assessed at each MTM encounter.Given the significant adverse effects of long-term NSAID treatment, reassessment of cardiovascular risk and GI bleeding risk should be conducted during each MTM encounter to ensure safety of continued treatment and the potential need for additional medications to reduce risk (eg, proton-pump inhibitors for GI bleeding risk).Assessment of potential adverse effects from analgesic therapy should be determined during each MTM encounter. Importantly, bleeding from NSAIDs and constipation, sedation, or respiratory depression associated with opioids should be monitored frequently.